Standout Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, ra... 2018 2026 2020 2023 218
  1. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study (2018)
    Florence Duffaud, Olivier Mir et al. The Lancet Oncology

Immediate Impact

52 standout
Sub-graph 1 of 23

Citing Papers

The emerging role of lactate in tumor microenvironment and its clinical relevance
2024 Standout
Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis
2024 Standout
2 intermediate papers

Works of Jessy Delaye being referenced

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
2018 Standout

Author Peers

Author Last Decade Papers Cites
Jessy Delaye 194 33 209 110 9 368
Seiko Sawada‐Kitamura 107 17 103 94 16 370
Paul Chih‐Hsueh Chen 137 44 89 92 9 375
Salma Alam 140 13 156 49 14 325
X. Tchiknavorian 266 75 148 55 13 358
S.‐F. Huang 119 34 144 51 10 305
Ying A. Wang 193 10 124 40 11 408
Chris Meyer 80 67 143 80 10 410
Éric Amela 123 7 272 64 18 398
Denise Stys‐Norman 179 36 200 39 9 329
Stephen Jurco 83 5 131 100 11 327

All Works

Loading papers...

Rankless by CCL
2026